GSK GSK Plc
Drug Manufacturers - General NYSE
Trading Signals (GSK)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $37.2
- Medium Support $37.81
- Weak Support $38.43
Resistance Levels
- Weak Resistance $39.65
- Medium Resistance $40.27
- Strong Resistance $40.88
Stop Loss Suggestions
- Conservative $37.79
- Moderate $38.12
- Aggressive $37.51
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | NEUTRAL |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | SELL |
|
Short & Medium Term |
| Volume Indicators | BUY |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (GSK)
Quarterly Outlook :
2025-07-10
Bullish Scenario
from current 11.72%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (16.71) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (54.43) is in bullish territory, indicating upward momentum. MACD line (0.81) is above Signal line (0.75) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.83, indicating the average weekly price range.
2025-07-10
Base Scenario
from current 2.81%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (16.71) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (54.43) is in bullish territory, indicating upward momentum. MACD line (0.81) is above Signal line (0.75) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.83, indicating the average weekly price range.
2025-07-10
Bearish Scenario
from current -9.37%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (16.71) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (54.43) is in bullish territory, indicating upward momentum. MACD line (0.81) is above Signal line (0.75) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.83, indicating the average weekly price range.
Annual Outlook
2025-07-10
Bullish Scenario
from current 23.44%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (16.71) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (54.43) is in bullish territory, indicating upward momentum. MACD line (0.81) is above Signal line (0.75) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.83, indicating the average weekly price range.
2025-07-10
Base Scenario
from current 5.62%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (16.71) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (54.43) is in bullish territory, indicating upward momentum. MACD line (0.81) is above Signal line (0.75) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.83, indicating the average weekly price range.
2025-07-10
Bearish Scenario
from current -18.75%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (16.71) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (54.43) is in bullish territory, indicating upward momentum. MACD line (0.81) is above Signal line (0.75) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.83, indicating the average weekly price range.
Technical Analysis (GSK)
Trend Identification
EMA
Exponential Moving Average
Current price (39.04) is between Short MA (39.26) and Long MA (38.54), or near one of them. This suggests consolidation or mixed signals. Short MA (39.26) is above Long MA (38.54), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (39.26, 38.54, 38.30) show mixed alignment, suggesting market indecision or range-bound activity. Market is in a choppy or sideways phase. Wait for a clearer trend to emerge before taking directional trades.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.0800) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are below the zero line, reinforcing bearish momentum (bearish territory). This is a strong sell signal. Consider short positions.
ADX
Average Directional Index
ADX (14.28) indicates a weak or non-existent trend (ranging market). +DI (29.90) is above -DI (25.77), suggesting a bullish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI (2025-07-10)
Relative Strength Index
RSI (50.40) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV (2025-07-10)
On-Balance Volume
OBV (16881310.00) is rising, indicating buying pressure and accumulation. Price is rising and OBV is rising. This is bullish confirmation, indicating buying pressure supports the price increase. Consider holding long positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-07-10)
Stochastic Oscillator
Stochastics (%K: 49.59, %D: 31.13) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed, potentially signaling an upward trend reversal or continuation. Stronger signal if this occurs below 50.
CCI (2025-07-10)
Commodity Channel Index
CCI (125.99) is above +100. This suggests a strong upward momentum and an overbought condition. Consider profit-taking or looking for short entries cautiously. Confirm with price action; if price is making higher highs, momentum is strong. Look for pullbacks to enter long.
Volatility Measurement
ATR (2025-07-10)
Average True Range
Current ATR is 0.7100. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-07-10)
Volatility Bands
Current price (39.04) is within the Bollinger Bands (36.66 - 41.87). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (39.26), indicating short-term bearish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals (GSK)
SAR (2025-07-10)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 37.79 is 3.20% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2025-07-10)
Neutral
Stochastic is in neutral territory (49.6). No clear overbought/oversold signal. Current crossover status: Bullish.
RSI (2025-07-10)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-07-10)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the middle of bands with normal bandwidth. No indication of imminent volatility expansion or reversal.
Holder List Top 20 (GSK)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Dodge & Cox Inc | INSTITUTIONAL | 78651833 | 3.87% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 60120517 | 2.96% | 2025-03-31 |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | MUTUALFUND | 58412777 | 2.87% | 2025-03-31 |
| Fisher Asset Management, LLC | INSTITUTIONAL | 30031815 | 1.48% | 2025-03-31 |
| Primecap Management Company | INSTITUTIONAL | 25708020 | 1.26% | 2025-03-31 |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | MUTUALFUND | 18118100 | 0.89% | 2025-03-31 |
| JTC Employer Solutions Trusteee Ltd | INSTITUTIONAL | 15260368 | 0.75% | 2025-03-31 |
| Goldman Sachs Group Inc | INSTITUTIONAL | 9062887 | 0.45% | 2025-03-31 |
| UBS Group AG | INSTITUTIONAL | 7872055 | 0.39% | 2025-03-31 |
| Price (T.Rowe) Associates Inc | INSTITUTIONAL | 7722314 | 0.38% | 2025-03-31 |
| Royal Bank of Canada | INSTITUTIONAL | 7581079 | 0.37% | 2025-03-31 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | MUTUALFUND | 7372027 | 0.36% | 2025-04-30 |
| State Street Corporation | INSTITUTIONAL | 6972998 | 0.34% | 2025-03-31 |
| Dodge & Cox Funds-Dodge & Cox Balanced Fund | MUTUALFUND | 5506295 | 0.27% | 2025-03-31 |
| Fidelity Devonshire Trust-Fidelity Series Value Discovery Fund | MUTUALFUND | 4376300 | 0.22% | 2025-04-30 |
| -Price (T.Rowe) International Value Equity Trust | MUTUALFUND | 4024747 | 0.2% | 2025-03-31 |
| Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund | MUTUALFUND | 3811128 | 0.19% | 2025-04-30 |
| VANGUARD FENWAY FUNDS-Vanguard PRIMECAP Core Fund | MUTUALFUND | 3450380 | 0.17% | 2025-03-31 |
| T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Value Eqy. Fd. | MUTUALFUND | 3142567 | 0.15% | 2025-03-31 |
| Fidelity Financial Trust-Fidelity Equity Dividend Income Fund | MUTUALFUND | 3116600 | 0.15% | 2025-04-30 |